CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Planned sale Chief People Officer sold 4,394 shares at $17.50 ($76,895)
- 4 Planned sale Chief People Officer sold 113,890 shares at $15.57 ($1,773,267)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 22,968 shares at $16.00 ($367,488)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Ofc Imm Med sold 12,604 shares at $16.85 ($212,377)
- 4 Planned sale Chief Scientific Officer sold 37,212 shares at an average $18.07 ($672,515)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 162,820 shares at $19.50 ($3,174,990)
- 4 Planned sale CEO and Chairman sold 160,734 shares at an average $19.10 ($3,070,747)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Ofc Imm Med sold 606,402 shares at an average $16.73 ($10,144,026)
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
Page 9 of 42 · 836 filings